Anviitha Agri Biotech Profile
Key Indicators
- Authorised Capital ₹ 4.20 M
as on 04-10-2024
- Paid Up Capital ₹ 0.10 M
as on 04-10-2024
- Company Age 8 Year, 7 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 6.10 M
as on 04-10-2024
- Revenue 5.85%
(FY 2020)
- Profit 222.49%
(FY 2020)
- Ebitda -1717.95%
(FY 2020)
- Net Worth 42.83%
(FY 2020)
- Total Assets 5.82%
(FY 2020)
About Anviitha Agri Biotech
The Company is engaged in the Agriculture Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 4.20 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹6.10 M.
Meesala Suresh, Durgaiah Muthyala, Sreedhar Purma, and One other member serve as directors at the Company.
- CIN/LLPIN
U01100TG2016PTC109928
- Company No.
109928
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
27 May 2016
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Anviitha Agri Biotech?
Board Members(4)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Meesala Suresh | Director | 27-May-2016 | Current |
Durgaiah Muthyala | Director | 27-May-2016 | Current |
Sreedhar Purma | Director | 27-May-2016 | Current |
Prathap Velumula | Director | 27-May-2016 | Current |
Financial Performance of Anviitha Agri Biotech.
Anviitha Agri Biotech Private Limited, for the financial year ended 2020, experienced modest growth in revenue, with a 5.85% increase. The company also saw a substantial improvement in profitability, with a 222.49% increase in profit. The company's net worth Soared by an impressive increase of 42.83%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations | |||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Anviitha Agri Biotech?
Unlock access to Anviitha Agri Biotech's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
- Anviitha Agri Biotech Private LimitedActive 8 years 6 months
Meesala Suresh, Durgaiah Muthyala and 2 more are mutual person
Charges (Loans)
Lender | Amount | Status |
---|---|---|
State Bank Of India Creation Date: 28 Sep 2020 | ₹6.10 M | Open |
How Many Employees Work at Anviitha Agri Biotech?
Unlock and access historical data on people associated with Anviitha Agri Biotech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Anviitha Agri Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Anviitha Agri Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.